Literature DB >> 21549724

Cholinergic modulation of mesolimbic dopamine function and reward.

Gregory P Mark1, Shkelzen Shabani, Lauren K Dobbs, Stephen T Hansen.   

Abstract

The substantial health risk posed by obesity and compulsive drug use has compelled a serious research effort to identify the neurobiological substrates that underlie the development these pathological conditions. Despite substantial progress, an understanding of the neurochemical systems that mediate the motivational aspects of drug-seeking and craving remains incomplete. Important work from the laboratory of Bart Hoebel has provided key information on neurochemical systems that interact with dopamine (DA) as potentially important components in both the development of addiction and the expression of compulsive behaviors such as binge eating. One such modulatory system appears to be cholinergic pathways that interact with DA systems at all levels of the reward circuit. Cholinergic cells in the pons project to DA-rich cell body regions in the ventral tegmental area (VTA) and substantial nigra (SN) where they modulate the activity of dopaminergic neurons and reward processing. The DA terminal region of the nucleus accumbens (NAc) contains a small but particularly important group of cholinergic interneurons, which have extensive dendritic arbors that make synapses with a vast majority of NAc neurons and afferents. Together with acetylcholine (ACh) input onto DA cell bodies, cholinergic systems could serve a vital role in gating information flow concerning the motivational value of stimuli through the mesolimbic system. In this report we highlight evidence that CNS cholinergic systems play a pivotal role in behaviors that are motivated by both natural and drug rewards. We argue that the search for underlying neurochemical substrates of compulsive behaviors, as well as attempts to identify potential pharmacotherapeutic targets to combat them, must include a consideration of central cholinergic systems.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549724      PMCID: PMC4495915          DOI: 10.1016/j.physbeh.2011.04.052

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  68 in total

1.  Cholinergic modulation of nucleus accumbens medium spiny neurons.

Authors:  Mischa de Rover; Johannes C Lodder; Karel S Kits; Anton N M Schoffelmeer; Arjen B Brussaard
Journal:  Eur J Neurosci       Date:  2002-12       Impact factor: 3.386

Review 2.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones.

Authors:  A D Smith; J P Bolam
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

3.  Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum.

Authors:  N J Woolf; L L Butcher
Journal:  Brain Res Bull       Date:  1989-12       Impact factor: 4.077

4.  Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell.

Authors:  P Rada; N M Avena; B G Hoebel
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin.

Authors:  J C Stoof; T De Boer; P Sminia; A H Mulder
Journal:  Eur J Pharmacol       Date:  1982-10-22       Impact factor: 4.432

6.  Synaptic relationships of enkephalinergic and cholinergic neurons in the nucleus accumbens of the rat.

Authors:  G E Meredith; H T Chang
Journal:  Brain Res       Date:  1994-12-19       Impact factor: 3.252

Review 7.  Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia.

Authors:  J S Yeomans
Journal:  Neuropsychopharmacology       Date:  1995-02       Impact factor: 7.853

8.  Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats.

Authors:  Anita J Bechtholt; Gregory P Mark
Journal:  Psychopharmacology (Berl)       Date:  2002-05-01       Impact factor: 4.530

9.  A quantitative study of cholinergic-dopaminergic interactions in the central nervous system.

Authors:  H De Souza; J Palermo-Neto
Journal:  Pharmacology       Date:  1982       Impact factor: 2.547

10.  Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.

Authors:  F P Bymaster; I Heath; J C Hendrix; H E Shannon
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

View more
  44 in total

1.  The evidence for the contribution of the autism susceptibility candidate 2 (AUTS2) gene in heroin dependence susceptibility.

Authors:  Wei Dang; Qian Zhang; Yong-Sheng Zhu; Xiao-Yun Lu
Journal:  J Mol Neurosci       Date:  2014-11-15       Impact factor: 3.444

Review 2.  Mechanisms underlying sleep-wake disturbances in alcoholism: focus on the cholinergic pedunculopontine tegmentum.

Authors:  Clifford M Knapp; Domenic A Ciraulo; Subimal Datta
Journal:  Behav Brain Res       Date:  2014-08-20       Impact factor: 3.332

3.  Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.

Authors:  M Garzón; A M Duffy; J Chan; M-K Lynch; K Mackie; V M Pickel
Journal:  Neuroscience       Date:  2013-08-15       Impact factor: 3.590

Review 4.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 5.  Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.

Authors:  Verónica Pastor; Marta Cristina Antonelli; María Eugenia Pallarés
Journal:  Neurotox Res       Date:  2016-10-24       Impact factor: 3.911

Review 6.  Systems level neuroplasticity in drug addiction.

Authors:  Matthew W Feltenstein; Ronald E See
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 7.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

Review 8.  Citicoline in addictive disorders: a review of the literature.

Authors:  Nicholas D Wignall; E Sherwood Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2014-06-20       Impact factor: 3.829

9.  Effects of cocaine and withdrawal on the mouse nucleus accumbens transcriptome.

Authors:  J E Eipper-Mains; D D Kiraly; M O Duff; M J Horowitz; C J McManus; B A Eipper; B R Graveley; R E Mains
Journal:  Genes Brain Behav       Date:  2012-11-27       Impact factor: 3.449

10.  High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice.

Authors:  Taline V Khroyan; Dennis Yasuda; Lawrence Toll; Willma E Polgar; Nurulain T Zaveri
Journal:  Biochem Pharmacol       Date:  2015-08-07       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.